 object antitumor activ acivicin patient recurr cn malign southwest oncolog group trial acivicin glutamin antagonist dose-limit schedule-depend cn toxic predict csf penetr intraven administr properti trial cn malign thirty-two patient recurr residu malign astrocytoma major patient multiform prior nitrosourea median age year southwest oncolog group swog perform statu major determin respons radiolog criteria tomograph CT and/or magnet reson imag mri tumor mass perpendicular plane cross-sect area standard solid tumor criteria respons patient stabl dose corticosteroid stabl improv perform statu neurolog examin object respons complet remiss year partial remiss day patient improv diseas requir partial remiss toxic mild nausea vomit patient studi due neurotox depress hallucin strict respons criteria trial activ agent carmustin bcnu object antitumor activ malign astrocytoma warrant studi